Cargando…

Troglitazone and Δ2Troglitazone Enhance Adiponectin Expression in Monocytes/Macrophages through the AMP-Activated Protein Kinase Pathway

Accumulating evidence indicates that the regimen to increase adiponectin will provide a novel therapeutic strategy for inflammation and cardiovascular disorders. Here, we tested the effect of troglitazone (TG) and its newly synthesized derivative, 5-[4-(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl-met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Jaw-Shiun, Chuang, Lee-Ming, Chen, Ching-Shih, Liang, Chan-Jung, Chen, Yuh-Lien, Chen, Ching-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189946/ https://www.ncbi.nlm.nih.gov/pubmed/25328285 http://dx.doi.org/10.1155/2014/726068

Ejemplares similares

In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer
por: Fujita, Megumi, et al.
Publicado: (2017)

Inhibition of cell motility by troglitazone in human ovarian carcinoma cell line
por: Yang, Yuh-Cheng, et al.
Publicado: (2007)

Effect of troglitazone on radiation sensitivity in cervix cancer cells
por: An, Zhengzhe, et al.
Publicado: (2012)

Troglitazone reverses the multiple drug resistance phenotype in cancer cells
por: Davies, Gerald F, et al.
Publicado: (2009)

Troglitazone and tumor inhibition: an evolving concept in the management of systemic malignancies
por: Kapoor, Shailendra
Publicado: (2012)

Antiproliferative effects and molecular mechanisms of troglitazone in human cervical cancer in vitro
por: Ye, Jinjun, et al.
Publicado: (2015)

A Retrospective Review of Thiazolidinediones with Development of a Troglitazone Conversion Protocol
por: Lindsey, Cameron, et al.
Publicado: (2003)

Troglitazone Induces Extracellular Matrix and Cytoskeleton Remodeling in Mouse Collecting Duct Cells
por: Corinaldi, Jaime, et al.
Publicado: (2012)

Troglitazone suppresses transforming growth factor beta-mediated fibrogenesis in retinal pigment epithelial cells
por: Cheng, Huey-Chuan, et al.
Publicado: (2008)

Troglitazone Reduces Glyoxalase I Protein Expression in Glioma and Potentiates the Effects of Chemotherapeutic Agents
por: Helgager, Jeffrey, et al.
Publicado: (2010)

Integrative Toxicoproteomics Implicates Impaired Mitochondrial Glutathione Import as an Off-Target Effect of Troglitazone
por: Lee, Yie Hou, et al.
Publicado: (2013)

Troglitazone Enhances the Apoptotic Response of DLD-1 Colon Cancer Cells to Photodynamic Therapy
por: Park, Hyunju, et al.
Publicado: (2016)

Troglitazone suppresses tumor cell growth and glutamine metabolism through a PPAR-independent mechanism
por: Reynolds, Miriam, et al.
Publicado: (2014)

Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes
por: Fukano, Kento, et al.
Publicado: (2019)

A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model
por: Zhong, Wen-Bin, et al.
Publicado: (2018)

Effect of troglitazone on tumor growth and pulmonary metastasis development of the mouse osteosarcoma cell line LM8
por: Aizawa, Junichi, et al.
Publicado: (2010)

Troglitazone suppresses telomerase activity independently of PPARγ in estrogen-receptor negative breast cancer cells
por: Rashid-Kolvear, Fariborz, et al.
Publicado: (2010)

Systems Pharmacology Modeling Predicts Delayed Presentation and Species Differences in Bile Acid-Mediated Troglitazone Hepatotoxicity
por: Yang, Kyunghee, et al.
Publicado: (2014)

Assessment of troglitazone induced liver toxicity in a dynamically perfused two-organ Micro-Bioreactor system
por: Materne, Eva-Maria, et al.
Publicado: (2013)

Mechanistic Insights into Side Effects of Troglitazone and Rosiglitazone Using a Novel Inverse Molecular Docking Protocol
por: Kores, Katarina, et al.
Publicado: (2021)

9-cis-Retinoic Acid and Troglitazone Impacts Cellular Adhesion, Proliferation, and Integrin Expression in K562 Cells
por: Hanson, Amanda M., et al.
Publicado: (2014)

Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines
por: Shen, Y-C, et al.
Publicado: (2004)

Troglitazone, a Ligand for Peroxisome Proliferator‐activated Receptor γ Inhibits Chemically‐induced Aberrant Crypt Foci in Rats
por: Kohno, Hiroyuki, et al.
Publicado: (2001)

PPARγ activation by troglitazone enhances human lung cancer cells to TRAIL-induced apoptosis via autophagy flux
por: Nazim, Uddin MD., et al.
Publicado: (2017)

Troglitazone, a PPAR-γ activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-α
por: Sasaki, Makoto, et al.
Publicado: (2005)

Troglitazone Attenuates TGF-β1-Induced EMT in Alveolar Epithelial Cells via a PPARγ-Independent Mechanism
por: Zhou, Beiyun, et al.
Publicado: (2012)

Troglitazone-Induced PRODH/POX-Dependent Apoptosis Occurs in the Absence of Estradiol or ERβ in ER-Negative Breast Cancer Cells
por: Lewoniewska, Sylwia, et al.
Publicado: (2021)

Troglitazone Induces G1 Arrest by p27(Kip1) Induction That Is Mediated by Inhibition of Proteasome in Human Gastric Cancer Cells
por: Takeuchi, Shigeru, et al.
Publicado: (2002)

Troglitazone Inhibits Matrix Metalloproteinase-9 Expression and Invasion of Breast Cancer Cell through a Peroxisome Proliferator-Activated Receptor γ-Dependent Mechanism
por: Hong, On-Yu, et al.
Publicado: (2018)

The antidiabetic drug troglitazone protects against PrP (106–126)-induced neurotoxicity via the PPARγ-autophagy pathway in neuronal cells
por: Moon, Ji-Hong, et al.
Publicado: (2021)

Aliskiren Improves Ischemia- and Oxygen Glucose Deprivation-Induced Cardiac Injury through Activation of Autophagy and AMP-Activated Protein Kinase
por: Chiang, Ming-Hsien, et al.
Publicado: (2017)

Plasma Adiponectin Levels Correlate Positively with an Increasing Number of Components of Frailty in Male Elders
por: Tsai, Jaw-Shiun, et al.
Publicado: (2013)

CDK5-induced p-PPARγ(Ser 112) downregulates GFAP via PPREs in developing rat brain: effect of metal mixture and troglitazone in astrocytes
por: Rai, A, et al.
Publicado: (2014)

The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells
por: Bolden, Adrienne, et al.
Publicado: (2012)

Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells
por: Chin, Li-Han, et al.
Publicado: (2015)

Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells
por: Chin, Li-Han, et al.
Publicado: (2017)

Correlation between plasma ZAG and adiponectin in older adults: gender modification and frailty specificity
por: Lee, Ya-Ping, et al.
Publicado: (2021)

Adiponectin Gene Polymorphism Is Selectively Associated with the Concomitant Presence of Metabolic Syndrome and Essential Hypertension
por: Leu, Hsin-Bang, et al.
Publicado: (2011)

Altered monocyte differentiation and macrophage polarization patterns in patients with breast cancer
por: Hung, Chih-Hsing, et al.
Publicado: (2018)

Self-reported exhaustion, physical activity, and grip strength predict frailty transitions in older outpatients with chronic diseases
por: Pao, Yu-Ching, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q41p8v79qukfis839b0ou8qbro